IL6 and hepatocellular carcinoma: Importantly, blocking IL-6 or IL-8 with neutralizing antibody partially reversed the increased spheroid formation ability, motility, and resistance ability to sorafenib of HCC cells after incubation with CM collected from fibroblasts pre-treated by miR1247-3p (Fig. 5d, g, i).